Focused screening for occult carotid artery disease: Patients with known heart disease are at high risk

Journal of Vascular Surgery

Volumn 39, Issue 1, 2004, Pages 44-50

  Rockman, Caron B ^a   Jacobowitz, Glenn R ^a   Gagne, Paul J ^a   Adelman, Mark A ^a   Lamparello, Patrick J ^a   Landis, Ronnie ^a   Riles, Thomas S ^a   Moore, Wesley S ^b   Ricotta, John J ^b   Blebea, John ^b   Flinn, William F ^b   Lavenson, George ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREVALENCE; PRIORITY JOURNAL; REIMBURSEMENT; RISK FACTOR; SCREENING; STROKE;

EID: 9144261161     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2003.07.008     Document Type: Article

References (37)

1. American Heart Association. 2002 Heart and stroke statistical update. Dallas: The Association; 2001.
2. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute nonintenventional therapy in ischemic stroke. JAMA 1999;282:2019-26.
3. Weinberger J. Prevention of ischemic stroke. Curr Cardiol Rep 2002;4:164-71.
4. Hart RG, Bailey RD. An assessment of guidelines for prevention of ischemic stroke. Neurology 2002;59:977-82.
5. Axelrod DA, Diwan A, Stanley JC, et al. Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg 2002;35:754-8.
6. Benade MM, Warlow CP. Cost of identifying patients for carotid endarterectomy. Stroke 2002;33:435-9.
7. Cronenwett JL, Birkmeyer JD, Nackman GB, Fillinger MF, Bech FR, Zwolak RM, Walsh DB. Cost-effectiveness of carotid endarterectomy in asymptomatic patients. J Vasc Surg 1997;25:298-309.
8. Derdeyn CP, Powers WJ. Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke 1996;27:1944-50.
9. Holloway KG, Benesch CT, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke 1999;30:1340-9.
10. Kuntz KM, Kent KC. Is carotid endarterectomy cost-effective? an analysis of symptomatic and asymptomatic patients. Circulation 1996;94:194-8.
11. Lee TT, Solomon NA, Heidenreich PA, Ochiert J, Garber AM. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med 1997;126:657-8.
12. Yin D, Carpenter JP. Cost-effectiveness of screening for asymptomatic carotid stenosis. J Vasc Surg 1998;27:245-55.
13. Zwolak RM. Coding and billing issues in the vascular laboratory. Semin Vasc Surg 2001;14:160-8.
14. Lavenson GS Jr. A new accurate, rapid and cost-effective protocol for stroke-prevention screening. Cardiovasc Surg 1998;6:590-3.
15. Carsten CG III, Elmore JR, Franklin DP, Thomas DD, Mordan F, Wood GC. Use of limited color-flow duplex for a carotid-screening project. Am J Surg 1999;178:174-7.
16. Jacobowitz GR, Rockman CB, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. A model for predicting occult carotid artery disease: screening is justified in a selected population. J Vasc Surg 2003;38:705-9.
17. Fine-Edelstein JS, Wolf PA, O'Leary DH, et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994;44:1046-50.
18. Mathiesen EB, Joakimsen O, Bonaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromso Study. Cerebrovasc Dis 2001;12:44-51.
19. Bogousslavsky J, Regli F, Van Melle G. Risk factors and concomitants of internal carotid artery occlusion or stenosis: a controlled study of 159 cases. Arch Neurol 1985;42:864-7.
20. Lernfelt B, Forsberg M, Blomstrand C, Mellstrom D, Volkmann R. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke 2002;33:224-9.
21. Simos PCG, Algra A, Eikelboom BC, Grobbee DE, van der Graaf Y, for the SMART study group. Carotid artery stenosis in patients with peripheral arterial disease: The SMART study. J Vasc Surg 1999;30:519-25.
22. Cheng SW, Wu LL, Ting AC, Lau H, Wong J. Screening for asymptomatic carotid stenosis in patients with peripheral vascular disease: a prospective study and risk factor analysis. Cardiovasc Surg 1999;7:303-9.
23. Archbold RA, Barakat K, Magee P, Curzen N. Screening for carotid artery disease before cardiac surgery: is current clinical practice evidence based? Clin Cardiol 2001;24:26-32.
24. Ascher E, Hingorani A, Yorkovich W, Ramsey PJ, Salles-Cunha S. Routine preoperative carotid duplex scanning in patients undergoing open-heart surgery: is it worthwhile? Ann Vasc Surg 2001;15:669-78.
25. Ascher E, DePippo P, Salles-Cunha S, Marchese J, Yorkovich W. Carotid screening with duplex ultrasound in elderly asymptomatic patients referred to a vascular surgeon: is it worthwhile? Ann Vasc Surg 1999;13:164-8.
26. de Virgilio C, Toosie K, Arnell T, et al. Asymptomatic carotid artery stenosis screening in patients with lower extremity atherosclerosis: a prospective study. Ann Vasc Surg 1997;11:374-7.
27. Ahn SS, Baker JD, Walden K, Moore WS. Which asymptomatic patients should undergo routine screening carotid duplex scan? Am J Surg 1991;162:180-3.
28. Marek J, Mills JL, Harvich J, Cui H, Fujitani RM. Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg 1996;24:572-7.
29. Kurvers HaH, van der Graaf Y, Blankensteijn JdJ, Visseren FLF, Eikelboom BcB. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only. J Vasc Surg 2003;37:1226-33.
30. Whitty CJM, Sudlow CLM, Warlow CP. Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful. Neurol Ncurosurg Psychiatry 1998;64:619-23.
31. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effects of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445-53.
32. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
33. Baker JD. Costs of duplex scanning and the impact of the changes in Medicare reimbursement. J Vasc Surg 1993;18:702-7.
34. Passman MA, Guzman RJ, Pierce R, Naslund TC. Impact of Medicare denials on noninvasive vascular diagnostic testing. J Vasc Surg 2001;34:846-53.
35. Rockman CB, Riles TS, Lamparello PJ, et al. Natural history and management of the asymptomatic, moderately stenotic internal carotid artery. J Vasc Surg 1997;25:423-31.
36. Muluk SC, Muluk VS, Sugimoto H, et al. Progression of asymptomatic carotid stenosis: a natural history study in 1004 patients. J Vasc Surg 1999;29:208-14.
37. Qureshi AI, Janardhan V, Bennett SE, Luft AR, Hopkins LN, Guterman LR. Who should be screened for asymptomatic carotid artery stenosis? experience from the Western New York Stroke Screening Program. J Neuroimaging 2001;11:105-11.